Schizophrenia Study In Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Schizophrenia
Interventions
DRUG

talnetant

DRUG

risperidone

Trial Locations (31)

11423

GSK Clinical Trial Call Center, Hollis

20016

GSK Clinical Trial Call Center, Washington D.C.

27509

GSK Clinical Trial Call Center, Butner

27603

GSK Clinical Trial Call Center, Raleigh

32789

GSK Clinical Trial Call Center, Winter Park

33161

GSK Clinical Trial Call Center, North Miami

33613

GSK Clinical Trial Call Center, Tampa

37212

GSK Clinical Trial Call Center, Nashville

44109

GSK Clinical Trial Call Center, Cleveland

45267

GSK Clinical Trial Call Center, Cincinnati

46143

GSK Clinical Trial Call Center, Greenwood

60194

GSK Clinical Trial Call Center, Hoffman Estates

71101

GSK Clinical Trial Call Center, Shreveport

73069

GSK Clinical Trial Call Center, Norman

73103

GSK Clinical Trial Call Center, Oklahoma City

75160

GSK Clinical Trial Call Center, Terrell

77401

GSK Clinical Trial Call Center, Bellaire

78729

GSK Clinical Trial Call Center, Austin

85251

GSK Clinical Trial Call Center, Scottsdale

90660

GSK Clinical Trial Call Center, Pico Rivera

90703

GSK Clinical Trial Call Center, Cerritos

91770

GSK Clinical Trial Call Center, Rosemead

91910

GSK Clinical Trial Call Center, Chula Vista

92123

GSK Clinical Trial Call Center, San Diego

92126

GSK Clinical Trial Call Center, San Diego

92845

GSK Clinical Trial Call Center, Garden Grove

92868

GSK Clinical Trial Call Center, Orange

95823

GSK Clinical Trial Call Center, Sacramento

06050

GSK Clinical Trial Call Center, New Britain

06519

GSK Clinical Trial Call Center, New Haven

08021

GSK Clinical Trial Call Center, Clementon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY